Development of the Nova Scotia Potential Donor Audit (PDA) Tool and 2020 Historic Performance Database: Lessons Learned From the First 1000 Medical Record Reviews.
Journal
Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
04
06
2023
revised:
26
07
2023
accepted:
21
08
2023
medline:
25
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Legislation and accountability frameworks are key components of high-performing deceased-donation systems. In 2021, Nova Scotia (NS), Canada, became the first jurisdiction in North America to enact deemed consent legislation and concurrently implemented mandatory referral legislation similar to that found in other Canadian provinces. Frontline financial resources were provided by the government to support the development of program infrastructure, including implementation of means to evaluate system performance. The Organ Donation Program (ODP), in collaboration with other stakeholders, developed a Potential Donor Audit (PDA) tool and database for referral intake and manual performance audits. Medical record reviews of deaths in the year before legislative change were conducted to pilot and revise the PDA and evaluate missed donation opportunities. The NS PDA was piloted on 1028 patient deaths. Of 518 patients (50.4%) who met clinical triggers for referral to the ODP, 72 (13.9%) were referred (86.1% missed referral rate). One hundred sixty-three patients met the NS definition of a potential donor; 53 (32.5%) were referred (110 missed potential donors). Referral consent rates reached 71.7% (n = 38 of 53 approaches). The actualized donation rate reported by Canadian Blood Services was 29.9 donors per million population (n = 34 donors). We documented high rates of missed referrals and missed potential donors before the enactment of mandatory referral and deemed consent legislation. The ODP has intentionally broadened clinical criteria for referral to shift the responsibility of identifying medically suitable potential donors from bedside clinicians to organ donation specialists. Lessons learned from our experience developing a PDA include the importance of early involvement of multiple stakeholders and ongoing modification of fields and workflow based on data availability and utility for clinical, educational, research, and reporting purposes.
Sections du résumé
Background
UNASSIGNED
Legislation and accountability frameworks are key components of high-performing deceased-donation systems. In 2021, Nova Scotia (NS), Canada, became the first jurisdiction in North America to enact deemed consent legislation and concurrently implemented mandatory referral legislation similar to that found in other Canadian provinces. Frontline financial resources were provided by the government to support the development of program infrastructure, including implementation of means to evaluate system performance.
Methods
UNASSIGNED
The Organ Donation Program (ODP), in collaboration with other stakeholders, developed a Potential Donor Audit (PDA) tool and database for referral intake and manual performance audits. Medical record reviews of deaths in the year before legislative change were conducted to pilot and revise the PDA and evaluate missed donation opportunities.
Results
UNASSIGNED
The NS PDA was piloted on 1028 patient deaths. Of 518 patients (50.4%) who met clinical triggers for referral to the ODP, 72 (13.9%) were referred (86.1% missed referral rate). One hundred sixty-three patients met the NS definition of a potential donor; 53 (32.5%) were referred (110 missed potential donors). Referral consent rates reached 71.7% (n = 38 of 53 approaches). The actualized donation rate reported by Canadian Blood Services was 29.9 donors per million population (n = 34 donors).
Discussion
UNASSIGNED
We documented high rates of missed referrals and missed potential donors before the enactment of mandatory referral and deemed consent legislation.
Conclusions
UNASSIGNED
The ODP has intentionally broadened clinical criteria for referral to shift the responsibility of identifying medically suitable potential donors from bedside clinicians to organ donation specialists. Lessons learned from our experience developing a PDA include the importance of early involvement of multiple stakeholders and ongoing modification of fields and workflow based on data availability and utility for clinical, educational, research, and reporting purposes.
Identifiants
pubmed: 37876919
doi: 10.1097/TXD.0000000000001545
pmc: PMC10593262
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1545Informations de copyright
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Références
Can J Anaesth. 2006 Jul;53(7):727-31
pubmed: 16803922
Transplantation. 2012 Dec 15;94(11):1167-71
pubmed: 23114533
Transplant Direct. 2020 Dec 15;7(1):e641
pubmed: 33335980
Intensive Care Med. 2016 Feb;42(2):264-7
pubmed: 26077047
Med J Aust. 2017 Sep 2;207(7):294-301
pubmed: 28954604
Crit Care Med. 2018 Aug;46(8):1318-1327
pubmed: 29782354
Can J Anaesth. 2019 Apr;66(4):432-447
pubmed: 30565159
Crit Care Med. 2017 Jun;45(6):989-992
pubmed: 28350643
Can J Anaesth. 2020 Mar;67(3):313-323
pubmed: 31768789
Can J Kidney Health Dis. 2021 Feb 20;8:2054358121992921
pubmed: 33680483
Transplant Direct. 2023 Apr 28;9(5):e1395
pubmed: 37138556
Transplant Direct. 2023 Apr 28;9(5):e1351
pubmed: 37138554
Can J Anaesth. 2023 May;70(5):886-892
pubmed: 36991298